Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sila Usar Incirli

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 24, 2019
Hemifacial spasm in sleep - A polysomnographic studySila Usar Incirli, Rezzak Yilmaz, Muhittin C Akbostanci
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 7, 2023
Dalfampridine as a promising agent in the management of hereditary spastic paraplegia: A triple-blinded, randomized, placebo-controlled pilot trialFerda Selcuk Muhtaroglu, Beliz Belgen Kaygisiz, Sila Usar Incirli, et al.
Clinical Neuropharmacology|July 15, 2024
Efficacy and Safety of Mirabegron Add-on Therapy After Failure With Solifenacin in Multiple Sclerosis Patients With Overactive Bladder: A Pilot StudySenem Ertugrul Mut, Ferda Selcuk, Sila Usar İncirli, et al.
Multiple Sclerosis and Related Disorders|May 17, 2021
A comprehensive assessment of patient experience and disease-related awareness in multiple sclerosis: A questionnaire-based nation-wide survey in TurkeySerkan Demir, Melih Tutuncu, Cihat Uzunkopru, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 24, 2019
Hemifacial spasm in sleep - A polysomnographic studySila Usar Incirli, Rezzak Yilmaz, Muhittin C Akbostanci
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 7, 2023
Dalfampridine as a promising agent in the management of hereditary spastic paraplegia: A triple-blinded, randomized, placebo-controlled pilot trialFerda Selcuk Muhtaroglu, Beliz Belgen Kaygisiz, Sila Usar Incirli, et al.
Clinical Neuropharmacology|July 15, 2024
Efficacy and Safety of Mirabegron Add-on Therapy After Failure With Solifenacin in Multiple Sclerosis Patients With Overactive Bladder: A Pilot StudySenem Ertugrul Mut, Ferda Selcuk, Sila Usar İncirli, et al.
Multiple Sclerosis and Related Disorders|May 17, 2021
A comprehensive assessment of patient experience and disease-related awareness in multiple sclerosis: A questionnaire-based nation-wide survey in TurkeySerkan Demir, Melih Tutuncu, Cihat Uzunkopru, et al.
Pageof 1